Moderate alcohol consumption is generally tolerated, but excessive drinking can increase dizziness, lower blood pressure, and reduce the effectiveness of avanafil. It is safest to limit alcohol intake around the time of sexual activity.
The tablet is a round, white pill embossed with the letters “EV” followed by the dosage strength “200/60”. Imprint codes help pharmacists verify authenticity.
Standard workplace drug screenings do not test for avanafil or dapoxetine. However, sports anti-doping agencies may consider avanafil a prohibited substance under certain circumstances; athletes should consult their governing body.
The individual ingredients, avanafil and dapoxetine, have separate MHRA approvals for ED and PE, respectively. The combination product Extra Super Avana does not have a distinct marketing authorization in the UK and is therefore used off-label.
Combining the two agents into one tablet simplifies dosing and may improve adherence. Pharmacologically, the effect is equivalent to taking avanafil and dapoxetine separately, provided the same doses are used.
Yes, but keep the medication in its original packaging with a copy of the prescription. Some countries may require a doctor’s letter or may restrict import of PDE5 inhibitors and SSRIs; check local regulations before travel.
If a sexual encounter is not imminent, simply omit the dose. Do not double the dose later; take a new tablet only when you are ready for sexual activity, respecting the once-daily limit.
St. John’s wort induces CYP3A4 and can lower avanafil levels, reducing efficacy. Ginkgo biloba has mild antiplatelet activity and may increase bleeding risk when combined with nitrate therapy. Discuss all supplements with a pharmacist.
Pricing varies by pharmacy and NHS prescribing policies. A combination tablet may reduce dispensing fees compared with two separate prescriptions, but exact cost depends on local formulary and patient eligibility for subsidies.
The tablet should be swallowed whole. Splitting or crushing may alter the release profile and affect absorption, potentially reducing efficacy or increasing side-effect risk.
Extra Super Avana is a combination pill that contains two active ingredients: avanafil (200 mg) and dapoxetine (60 mg). The product is formulated as a single oral tablet and is intended for adult men who experience both erectile dysfunction (ED) and premature ejaculation (PE). In the United Kingdom the medication is classified as a Prescription-Only Medicine (POM) and must be prescribed by a qualified healthcare professional.
Because the brand name Extra Super Avana is not listed in publicly available regulatory databases, this article is based on the known properties of its component drugs-avanafil, a phosphodiesterase type 5 (PDE5) inhibitor, and dapoxetine, a short-acting selective serotonin reuptake inhibitor (SSRI).
Avanafil belongs to the PDE5 inhibitor class. It blocks the enzyme phosphodiesterase type 5, which normally degrades cyclic guanosine monophosphate (cG → cGMP) in the smooth muscle of the penile corpora cavernosa. By preserving cGMP levels, avanafil enhances nitric-oxide-mediated vasodilation, allowing increased blood flow into the penis and facilitating erection when sexual stimulation occurs.
Dapoxetine is a short-acting SSRI that increases synaptic serotonin by inhibiting its reuptake. Elevated serotonin activity in the central nervous system lengthens the ejaculatory latency time, helping men achieve better control over ejaculation.
When taken together, the two agents target the two most common male sexual performance concerns: the ability to achieve a firm erection (via avanafil) and the ability to delay ejaculation (via dapoxetine).
Because the combination product itself does not have a separate marketing authorization, clinicians prescribe it off-label for patients who require simultaneous management of both conditions. The decision to use the combination should be made after a full clinical assessment and when monotherapy with either agent alone does not provide satisfactory outcomes.
Small-scale clinical studies and observational reports have investigated the simultaneous use of a PDE5 inhibitor with dapoxetine in men who experience both ED and PE. These investigations suggest that combined therapy can improve overall sexual satisfaction compared with either drug alone. However, the evidence is limited to short-term trials and does not constitute formal regulatory approval.
Off-label use requires medical supervision and individualized risk assessment.
This article provides educational information about Extra Super Avana and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
